Skip to main content
. 2010 Oct 26;1(1):43–128. doi: 10.1007/s13539-010-0001-7
Placebo 100 U EPO 500 U EPO 2,500 U EPO 5,000 U EPO 0.3 mg IGF-1 3 mg IGF-1
N 78 20 16 14 16 14 15
Cell No. (×109) 2.98 ± 0.27 3.03 ± 0.29 2.91 ± 0.26 2.76 ± 0.32 2.25 ± 0.25 2.84 ± 0.42 2.5 ± 0.28
Delta BW (g) −53.7 ± 1.8 −30.6 ± 9.6*** −39.6 ± 8.9* −29.1 ± 10.1*** −47.4 ± 5.9 −39.6 ± 11.1* −42.7 ± 8.8*
Delta lean mass (g) −39.8 ± 1.6 −23.7 ± 7.4** −30.3 ± 6.81* −21.6 ± 7.7*** −35.4 ± 4.6 −28.8 ± 8.4* −30.6 ± 7.4
Delta fat mass (g) −12.4 ± 0.4 −8.0 ± 1.7*** −10.5 ± 1.5 −8.4 ± 1.5*** −11.2 ± 0.9 −12.4 ± 1.9 −11.0 ± 1.3
Food (g/24 h) 4.3 ± 0.48 7.85 ± 1.66** 6.56 ± 1.73 6.57 ± 1.89 5.38 ± 1.19 2.5 ± 1.66 11.8 ± 9.82
Activity (counts/24 h) 29,509 ± 1,775 38,550 ± 4,412* 36,915 ± 3,854 38,893 ± 6,012 40,342 ± 4,630* 35,685 ± 4,637 29,962 ± 5,139